Services
Inventvacc offers diverse services in biologics from process-to-end user. We have wide ranging experience in process development, optimization, servicing analytical needs and manufacturing from early clinical trials through commercialization. We can assist in advancing your program by leveraging our subject matter experts in clinical trials, commercial market access, automated commercial manufacturing, protein purification, cell culture, conjugation chemistry.
Commercial Market Access
We excel in the commercialization and localization of biologicals in the below regions, in addition to exploring local manufacturing opportunities. Through our network of industry experts and prominent local partners with access to both government and private sectors.
We currently operate throughout the following regions:
- North America (Canada & USA)
- Latin America (LATAM)
- European Union Countries (EU)
- Middle East & Africa (MEA)
- Japan
Clinical Trials
Whether your product is in Phase 1, Phase 2 or Phase 3 we have the expertise to support your clinical trial strategy globally, and to recruit relevant subjects in a timely manner. We can co-invest in clinical trials pertaining to innovative biological products that provide a high quality of life.
Areas of Co-Development
- Vaccines
- Immuno-oncology
- Orphan Drugs
Process Development
InventVacc Process Development and Analytical Development capabilities support the development and optimization of protein processes. Our scientific team works closely with our partners to optimize their process in order to comply with phase-appropriate regulatory guidelines and ensure a consistent, high-quality product throughout clinical development and commercialization.
For partners with earlier stage processes, we work to improve their processes and recommend combinations of approaches, with the goal of improving product quality, step yields, and reducing manufacturing cycle times.
Automation Design
For state-of-the-art manufacturing, InventVacc is implementing a comprehensive automation strategy with a focus on our key goals – maximum use of automation, tight integration of the entire process train to support continuous manufacturing, and maximum automated data collection for increased observability and monitoring. We are aligning our strategy with existing well-established integration frameworks ISA-95, process control standards ISA-88, and adopting Pharma 4.0 principles.
Clinical & Commercial Manufacturing
Through the combination of our Operational Strategy and Proprietary Electronic Data Management System, InventVacc enables our Partners to deliver their products to patients efficiently, cost-effectively, and with the highest quality. Defined process flows ensure product integrity (Chain of Identity & Chain of Custody) from material through processing, storage, and shipment from InventVacc to the Health Care Provider. All manufacturing and logistics data are monitored 24/7 by the cross functional InventVacc team.
We are currently in the process of building an exciting and
innovative manufacturing facility in
Montreal.
